NNOX vs. ESTA, AORT, MDXG, PLSE, SILK, BLFS, EYE, AVNS, LQDA, and CATX
Should you be buying Nano-X Imaging stock or one of its competitors? The main competitors of Nano-X Imaging include Establishment Labs (ESTA), Artivion (AORT), MiMedx Group (MDXG), Pulse Biosciences (PLSE), Silk Road Medical (SILK), BioLife Solutions (BLFS), National Vision (EYE), Avanos Medical (AVNS), Liquidia (LQDA), and Perspective Therapeutics (CATX). These companies are all part of the "medical equipment" industry.
Establishment Labs (NASDAQ:ESTA) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.
Nano-X Imaging has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.
In the previous week, Establishment Labs had 10 more articles in the media than Nano-X Imaging. MarketBeat recorded 12 mentions for Establishment Labs and 2 mentions for Nano-X Imaging. Establishment Labs' average media sentiment score of 0.62 beat Nano-X Imaging's score of 0.13 indicating that Nano-X Imaging is being referred to more favorably in the news media.
Establishment Labs has a net margin of -53.12% compared to Establishment Labs' net margin of -611.89%. Establishment Labs' return on equity of -31.57% beat Nano-X Imaging's return on equity.
Establishment Labs received 87 more outperform votes than Nano-X Imaging when rated by MarketBeat users. However, 68.42% of users gave Nano-X Imaging an outperform vote while only 61.75% of users gave Establishment Labs an outperform vote.
72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 11.4% of Establishment Labs shares are owned by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Establishment Labs has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 2.04, meaning that its stock price is 104% more volatile than the S&P 500.
Establishment Labs currently has a consensus target price of $54.00, indicating a potential upside of 12.03%. Nano-X Imaging has a consensus target price of $16.25, indicating a potential upside of 89.17%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Establishment Labs.
Summary
Nano-X Imaging beats Establishment Labs on 11 of the 18 factors compared between the two stocks.
Get Nano-X Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nano-X Imaging Competitors List
Related Companies and Tools
